# Dreavent

Dreavent is a Private Equity based in Cambridge, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Cambridge, United States
- **Region:** North America
- **Address:** Cambridge, United States
- **Founded:** 2020
- **Assets under management:** Undisclosed
- **Website:** www.dreaventcapital.com
- **LinkedIn:** https://www.linkedin.com/company/dreavent

## Regulatory record

- **CRD number:** 317637
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/317637

## About

Dreavent Capital is a Boston-based venture capital firm focused on biotech investments. It uses a structured Bio Asset Engineering model that starts from confirmed pharmaceutical demand and works backwards to select and develop science, with a pharmaceutical partner engaged before capital is deployed. Spain is the first market for connecting scientific ecosystems to Boston’s biotech infrastructure, via a model designed to scale.

## Sectors

- Private Equity

## People

- Gorka Fius — Managing Partner
- Wendy Nelson — PhD, Partner
- William S. Korinek — PhD, Partner
- Brian Gallagher Jr. — PhD, Venture Partner
- Charles Kunsch — PhD, Venture Partner
- Elaine V. Jones — PhD, Senior Advisor
- David Lagares — PhD, MBA, Venture Partner
- Carolina Salcedo — PhD, Principal
- Rosa Gonzalez — Scouting
- Elena Rivas — Scouting
- Peter Choo — Asset Lead
- Lloyd Appel — CFO

## Questions

### What asset classes does Dreavent target?

Dreavent targets early-stage startups, secondaries, and pre-IPO opportunities.

## Related profiles

- [Dream Ventures](https://altss.com/profile/dream-ventures)
- [Dreher Financial Partners](https://altss.com/profile/dreher-financial-partners)

---

Last updated: 2026-08-11T15:06:35.052Z

Canonical page: https://altss.com/profile/dreavent

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology